A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study
Open accessThe DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To determine the most cost-effective method of screening for atrial fibrillation (AF) in the population aged 65 years and over, as well as its prevalence and incidence in this age group. Also to evaluate the relative cost-effectiveness of different methods of recording and interpreting the electrocardiogram (ECG) within a screening programme. DESIGN: Multicentred randomised controlled trial. Purposefully selected general practices were randomly allocated to 25 intervention practices and 25 control practices. SETTING: Fifty primary care centres across the West Midlands, UK. PARTICIPANTS: Patients aged 65 years and over. INTERVENTIONS: GPs and practice nurses in the intervention practices received education on the importance of AF detection and ECG interpretation. Patients in the intervention practices were randomly allocated to systematic (n = 5000) or opportunistic screening (n = 5000). Prospective identification of pre-existing risk factors for AF within the screened population enabled comparison between targeted screening of people at higher risk of AF and total population screening. MAIN OUTCOME MEASURES: AF detection rates in systematically screened and opportunistically screened populations in the intervention practices were compared with AF detection rate in 5000 patients in the control practices. The screening period was 12 months. RESULTS: Baseline prevalence of AF was 7.2%, with a higher prevalence in males (7.8%) and patients aged 75 years and over (10.3%). The control population demonstrated higher baseline prevalence (7.9%) than either the systematic (6.9%) or opportunistic (6.9%) intervention population. In the control population 47 new cases were detected (incidence 1.04% per year). In the opportunistic arm 243 patients without a baseline diagnosis of AF were found to have an irregular pulse, with 177 having an ECG, yielding 31 new cases (incidence 0.69% per year). A further 44 cases were detected outside the screening programme (overall incidence 1.64% per year). In the systematic arm 2357 patients had an ECG yielding 52 new cases (incidence 1.1% per year). Of these, 31 were detected by targeted screening and a further 21 by total population screening. A further 22 cases were detected outside the screening programme (overall incidence 1.62% per year). In terms of ECG interpretation, computerised decision support software (CDSS) gave a sensitivity of 87.3%, a specificity of 99.1% and a positive predictive value (PPV) of 89.5% compared with the gold standard (cardiologist reporting). GPs and practice nurses performed less well. The only difference in performance between intervention populations and controls was that practice nurses from the control arm performed less well than with intervention practice nurses on interpretation of limb-lead (PPV 38.8% versus 20.8%) and single-lead (PPV 37.7% versus 24.0%) ECGs. The within-trial economic evaluation results showed the lowest incremental cost to be for the opportunistic arm, with an incremental cost-effectiveness ratio of 337 pounds Sterling for each additional case detected compared to the control arm. Opportunistic screening dominated both more intensive screening strategies. Model-based analyses showed small differences in cost and quality-adjusted life-years for different methods and intensities of screening, but annual opportunistic screening resulted in the lowest number of ischaemic strokes and greatest proportion of cases of AF diagnosed. Probabilistic sensitivity results indicated that there was a probability of approximately 60% that screening from the age of 65 years was cost-effective in both men and women. CONCLUSIONS: The results of the study indicated that in terms of a screening programme for atrial fibrillation in patients 65 and over, the only strategy that improved on routine practice was opportunistic screening, model-based analyses indicated that there was a probability of approximately 60% of annual opportunistic screening being cost effective. It is suggested that the following topics are worthy of further investigation: the effect of the implementation of a screening programme for AF on the uptake and maintenance of anticoagulation in patients aged 65 years and over; an evaluation of the role of CDSS in the diagnosis of cardiac arrythmias; the best method for routinely detecting paroxysmal AF; ways of improving healthcare professionals' performance in ECG interpretation; development of a robust economic model to incorporate data on new therapeutic agents for use as thromboprophylactic agents for patients with AF, and an evaluation of the relative risk of stroke for patients with incident as opposed to prevalent AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“reports of other screening instruments have suggested minimal burden and disruption of the clinical workflow.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [460]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A data monitoring committee will often comprise members from a variety of disciplines.363 451 452”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [363]
Experimental — accuracy not yet measuredIn the citing paper
“Blinding of data monitoring committee members is generally discouraged.363”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [363]
In the citing paper
“Independence, particularly from the sponsor and trial investigators, is a key characteristic of the data monitoring committee and can be broadly defined as the committee comprising members who are “completely uninvolved in the running of the trial and who cannot be unfairly influenced (either directly or indirectly) by people, or institutions, involved in the trial.”363 452”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [363]
In the citing paper
“Opportunistic screening for silent AF seems cost-effective in elderly populations (e.g.> 65 years), 131 and similar effects have been reported using single-lead ECG screening in other at-risk populations.132,133”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [131]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Marteau, T. M., & Bekker, H. (1992) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.1992.tb00997.x · Cited by 3,238
Principles and Practice of Screening for Disease.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-5-1085_2 · Cited by 3,066
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Feinberg, W. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.469 · Cited by 2,274
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Petersen, P., Godtfredsen, J., Boysen, G., Andersen, E., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,820
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
Principles and Practice of Screening for Disease.
Zavon, M. R. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.1969.00300130131020 · Cited by 1,356
Research works printed but not linked: 16
- [10]10. Lake RR, Cullen KJ, deKlerk NH, McCall MG, Rosman DL. Atrial fibrillation in an elderly population. Aust N Z J Med 1989;19:321-6.
- [11]11. Philips SJ, Whisnant J, O'Fallon WM, Frye RL. Prevalence of cardiovascular disease and diabetes in residents of Rochester, Minnesota. Mayo Clin Proc 1990;65:344-59.
- [15]15. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991;18:349-55.
- [19]19. Laupacis A, Albers G, Connolly S. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994;154:1449-57.
- [23]23. Albers GW. Atrial fibrillation and stroke. Arch Intern Med 1994;154:1443-8.
- [24]24. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low- intensity, fixed-dose warfarin plus aspirin for high- risk patients with atrial fibrillation: Stroke References Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348:633-8.
- [34]34. Atrial Fibrillation Investigators. The efficacy of aspirin in patients with atrial fibrillation: analysis of pooled data from 3 randomised trials. Arch Intern Med 1997;157:1237-40.
- [35]35. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation. Ann Intern Med 1992;116:6-12.
- [38]38. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost effectiveness analysis in medicine and health. Oxford: Oxford University Press; 1996.
- [41]41. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiological features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 1982;306:1018-22.
- [44]44. Hobbs FDR. Should all patients with atrial fibrillation be assessed by a cardiologist? Plenary session. Proceedings from Consensus Conference on the Management of Atrial Fibrillation. Edinburgh: RCP Edinburgh; 1998.
- [57]57. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer MD. Prevalence of diagnosed atrial fibrillation in adults. JAMA 2001;285:2370-5.
- [60]60. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-6. J Neurol Neurosurg Psychiatry 1990;53:16-22.
- [63]63. Office for National Statistics. Health Statistics Quarterly, 22. London: Office for National Statistics; 2004.
- [67]67. Robinson A, Thomson R, Parkin D, Sudlow M, Eccles M. How patients with atrial fibrillation value different health outcomes. Journal of Health Services and Research Policy 2001;6:92-8. References
- [73]73. Gray JAM. Dimensions and definitions of screening. Milton Keynes: NHS Executive Anglia; Oxford: Research and Development Directorate; 1996.
Cited by
Items 301–400 of 437
Review of Screening Studies for Atrial Fibrillation in Rural Populations of 11 Countries
Gavino, A., & McLachlan, C. S. (2017) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2017.11929615 · Cited by 5
“A 12-lead ECG remains the gold standard for AF screening (53).”
BackgroundHoben, M., Chamberlain, S. A., O’Rourke, H. M., Elliott, B., Shrestha, S., Devkota, R., Thorne, T. E., Lam, J., Banerjee, S., Hughes, L., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-041318 · Cited by 6
Curricular-driven screening for atrial fibrillation at community pharmacies
Bleske, B. E., Raley, R. E., Hunter, T. S., & Anderson, J. R. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.10.017 · Cited by 5
Murphy, R., Waters, R., Murphy, A. W., McDermott, S., Reddin, C., Hernon, O., Davies, N. J. H., Alvarez‐Iglesias, A., Twomey, E., O’Shea, E., et al. (2025) · QJM · doi:10.1093/qjmed/hcaf001 · Cited by 5
“20 Our choice of intervention, a reusable ELR, has implications for the sustainability of the screening approach in contrast to other single use ELRs (e.g. Zios patch), and with the right investment has the potential to be scaled up to be used in a similar fashion to successful improvements in the…”
Goma, F. M., & Kalinchenko, S. (2015) · Medical Journal of Zambia · Cited by 4
Sevinç, D., Paşaoğlu, L., Çoşkun, R., Atci, N., & Alımlı, A. G. (2016) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2015.12.009 · Cited by 4
Opportunistic screening for atrial fibrillation.
Holding, S., Russell, C., & Tyndall, K. (2013) · PubMed · Cited by 4
Research into practice: management of atrial fibrillation in general practice
Fitzmaurice, D. A., & Hobbs, R. F. (2014) · British Journal of General Practice · doi:10.3399/bjgp14x682057 · Cited by 6
Self-citationManaging diabetes in hospitalized patients with chronic kidney disease
Iyer, S. N., & Tanenberg, R. J. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83a.14189 · Cited by 4
Ibanez-Bruron, M. C., Solebo, A. L., Cumberland, P. M., & Rahi, J. S. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018578 · Cited by 4
Antonio, R. S., Guasch, E., Tolosana, J. M., & Mont, L. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2019.1550720 · Cited by 6
Diagnostic accuracies of screening for atrial fibrillation by cardiac nurses versus radiographers
Kvist, L. M., Vinter, N., Urbonavičienė, G., Lindholt, J. S., Diederichsen, A. C. P., & Frost, L. (2019) · Open Heart · doi:10.1136/openhrt-2018-000942 · Cited by 8
“In our study, 4 cardiac nurses assessed all ECGs compared with the 22 nurses and GPs in the SAFE study.(14) An opportunistic screening study for AF in men and women >65 years of age (mean age 76) entering pharmacies in Sydney, Australia, reported the diagnostic performance of single-lead ECG assessed by pharmacists (t…”
MethodResultInfluentialАзатовна, Т. И., Vaskovskiy, V. A., Artukhina, E. A., Антипина, Н. А., Николаева, А. А., Smirnov, G. Y., Sizov, V. A., Bukharev, A. E., Fadeeva, O. V., Голанов, А. В., et al. (2021) · Journal of Arrhythmology · doi:10.35336/va-2020-4-33-41 · Cited by 4
Screening for Atrial Fibrillation and the Role of Digital Health Technologies
Richardson, E., Hall, A., & Mitchell, A. R. J. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88660 · Cited by 6
Senoo, K., Nakata, M., Teramukai, S., Kumagai, M., Yamamoto, T., Nishimura, H., Lip, G. Y. H., & Matoba, S. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0864 · Cited by 4
Self-citationMechanisms of Atrial Fibrillation
Arora, R., & Koduri, H. K. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5316-0_31 · Cited by 4
Atrial fibrillation in the ‘real world’: undecided issues
Nieuwlaat, R., Eurlings, L. W. M., Capucci, A., & Crijns, H. J. G. M. (2007) · European Heart Journal Supplements · doi:10.1093/eurheartj/sum067 · Cited by 4
Senoo, K., Nakata, M., Teramukai, S., Yamamoto, T., Nishimura, H., & Matoba, S. (2020) · Circulation Reports · doi:10.1253/circrep.cr-20-0067 · Cited by 4
Electrocardiography Screening for Atrial Fibrillation—Reply
Curry, S. J., Krist, A. H., & Owens, D. K. (2018) · JAMA · doi:10.1001/jama.2018.17768 · Cited by 4
Spector, A. E., Melville, M., Craig, C., Henderson, C., Hiskey, S., Knapp, M. R. J., Kusel, Y., Oliver, K. D., Robinson, L. A., Royan, L., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-093249 · Cited by 3
Shah, S. J., Iyer, J. M., Agha, L., Chang, Y., Ashburner, J. M., Atlas, S. J., McManus, D. D., Ellinor, P. T., Lubitz, S. A., & Singer, D. E. (2025) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.124.011482 · Cited by 4
Pucci, G., Santoni, E., Bisogni, V., Calandri, C., Cerasari, A., Dominioni, I., Sanesi, L., D’Abbondanza, M., Veca, V., & Vaudo, G. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02691-2 · Cited by 4
Screening for Atrial Fibrillation in Community and Primary Care Settings: A Scoping Review
Lakkireddy, D. (2021) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2452 · Cited by 4
Zabihi, S., Duffy, L., Kelleher, D., Lord, K., Dar, A., Koutsoubelis, F., Banks, S., Rapaport, P., Mason, C., Vickerstaff, V., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-066166 · Cited by 4
Convergent ablation for persistent atrial fibrillation: A UK multicentre perspective
Mannakkara, N. N., Khan, I., Ghazanfar, A., Wijesuriya, N., Mehta, V. S., de Vere, F., Howell, S., Adhya, S., Porter, B., Child, N. M., et al. (2024) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16399 · Cited by 4
Orlowski, A., Wilkins, J., Ashton, R., Slater, R., Smith, W., & Belsey, J. (2020) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2019-0125 · Cited by 3
New methodological approaches to atrial fibrillation drug discovery
Wong, C., & Tse, H. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1826432 · Cited by 3
Beerten, S. G., Proesmans, T., & Vaes, B. (2021) · Trials · doi:10.1186/s13063-021-05497-x · Cited by 4
Antithrombotic selection and risk factor management in ischemic stroke and transient ischemic attack
Katz, B. S., & Flemming, K. D. (2014) · Neurosurgical FOCUS · doi:10.3171/2013.10.focus13402 · Cited by 3
Management of atrial fi brillation
Lip, G. Y. H., & Tse, H. (2007) · Cited by 3
Self-citationHow Can We Avoid a Stroke Crisis in the Asia-Pacific Region?
Goto, S., Hankey, G. J., Hills, M. T., Hu, D., & Hu, H. (2011) · Cited by 3
Dépistage et implications cliniques de la fibrillation atriale silencieuse
Guénancia, C., Garnier, F., Mouhat, B., Béjot, Y., Maillot, N., Fichot, M., Fauchier, L., & Cottin, Y. (2017) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2017.08.006 · Cited by 3
Burns, R. B., ZIMETBAUM, P. J., Lubitz, S. A., & Smetana, G. W. (2019) · Annals of Internal Medicine · doi:10.7326/m19-1126 · Cited by 3
Yang, X., Huang, J., Huang, Z., Xue, Y., Deng, H., & Cao, X. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm36262 · Cited by 2
“With technological advances and the development of effective anticoagulant treatments, a variety of AF screening initiatives, such as SAFE [12], STROKESTOP [13], AF-CATCH [14], and REHEAR-AF [15], have emerged and shown effectiveness in identifying patients with undiagnosed AF; however, the…”
InfluentialDao‐Tran, T., Kenny, D., Welch, A., Brittain, D., Lendich, K., Thompson, J. F., Parkin, B., Nunn, J., Vos, G., & Comans, T. A. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-096517 · Cited by 2
Alagöz, C., Phatharodom, S., & Guez, A. (2015) · International Conference on Modeling, Simulation, and Applied Optimization · doi:10.1109/icmsao.2015.7152242 · Cited by 2
Primärprävention des Schlaganfalls – Was ist neu?
Poppert, H., Sander, K., Etgen, T., & Sander, D. (2011) · Aktuelle Neurologie · doi:10.1055/s-0031-1295470 · Cited by 1
Preventative Measures of Stroke in Patients With Atrial Fibrillation.
Adlan, A., & Lip, G. Y. H. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.399 · Cited by 2
Self-citationPatel, S., Kongnakorn, T., Nikolaou, A., Javaid, Y., & Mokgokong, R. (2023) · Journal of Medical Economics · doi:10.1080/13696998.2023.2179210 · Cited by 3
2025 Thai guideline for the diagnosis and management of atrial fibrillation
Ngarmukos, T., Methavigul, K., Rungpradubvong, V., Apiyasawat, S., Wongcharoen, W., Pumprueg, S., Boonyapisit, W., Suwanagool, A., Chantrarat, T., Makarawate, P., et al. (2025) · Asian Biomedicine · doi:10.2478/abm-2025-0028 · Cited by 3
Xiong, Q., & Lip, G. Y. H. (2015) · Current Treatment Options in Neurology · doi:10.1007/s11940-014-0331-4 · Cited by 3
Self-citationPlace de la médecine connectée dans la détection de la fibrillation atriale
Saoudi, N. C., Latcu, G., Enache, B., Yaïci, K., Zarqane, N., Benhenda, N., & Pathak, A. (2021) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2021.09.014 · Cited by 3
Dieckelmann, M., González‐González, A. I., Banzer, W. B., Berghold, A., Jeitler, K., Pantel, J., Schall, A., Tesky, V. A., & Siebenhofer, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-063396 · Cited by 2
Cost-Effectiveness of Atrial Fibrillation Screening Strategies: A Systematic Review
Gorji, H. A., Khosravi, M., Mahmoodi, R., Hasoumi, M., Souresrafil, A., Alipour, V., Rezapour, A., Hajahmadi, M., & Azari, S. (2023) · Iranian Journal of Public Health · doi:10.18502/ijph.v52i4.12435 · Cited by 7
Predictors of participation in atrial fibrillation screening among community residents in China
Gu, H., Huang, J., Qiao, S., Chen, X., & Cao, X. (2023) · Heart & Lung · doi:10.1016/j.hrtlng.2023.04.015 · Cited by 2
Ige, J. J., Alston, A., Boreland, V., Caudwell, M., Ashbourne, R., Ford, B., Katsere, F., & Banham, G. (2024) · BMJ Open Quality · doi:10.1136/bmjoq-2024-002883 · Cited by 2
Better prevention of stroke through screening for atrial fibrillation
James, M. A., & Campbell, J. L. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x641294 · Cited by 2
Camm, A. J., Kirchhof, P. F., Ernst, S., Gelder, I. C. V., Hindricks, G., Heidbüchel, H., Colonna, P., Goette, A., Hohloser, S. H., Kolh, P. H., et al. (2010) · Cited by 2
Yang, Y. T., & Ortendahl, J. D. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1546681 · Cited by 1
Lee, J., Kim, T., Park, J., Joung, B., & Choi, E. (2021) · Korean Journal of Medicine · doi:10.3904/kjm.2021.96.2.76 · Cited by 1
Carlo, A. D., Mori, F., Consoli, D., Bellino, L., Zaninelli, A., Baldereschi, M., D’Alfonso, M. G., Gradia, C., Cattarinussi, A., Sgherzi, B., et al. (2022) · Aging Clinical and Experimental Research · doi:10.1007/s40520-022-02140-w · Cited by 1
“A 12-lead ECG read by a cardiologist is recognized as the gold standard for the diagnosis of AF [18].”
MethodAmbrosio, L., Hislop, K., Fuentes, N. S., Driessens, C., & Portillo, M. C. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-077978 · Cited by 1
Murkamilov, I. T., Айтбаев, К. А., Raimzhanov, Z. R., Yusupova, Z. F., Yusupova, T. F., Zakirov, O. T., & Yusupov, F. A. (2024) · Bulletin of Science and Practice · doi:10.33619/2414-2948/98/23 · Cited by 1
ERGASHEVA, U. P., Панченко, Е. П., Chernyshenko, C. G., Dmitrieva, E. A., Kislova, M. I., Fedotkina, Y. A., Yarovaya, E. B., Rimashevskaya, E., Ptushkin, V. V., & Nikitin, E. A. (2026) · Terapevticheskii arkhiv · doi:10.26442/00403660.2026.01.203492 · Cited by 1
Present state and future of screening for atrial fibrillation: a state-of-the-art review
Svennberg, E., & Khan, M. (2026) · Heart · doi:10.1136/heartjnl-2025-326121 · Cited by 2
Dahan, S., Sherer, J. A., Plakht, Y., Sindre, R. B., Cramariuc, D., Khurshid, S. S., Al‐Alusi, M. A., Ellinor, P. T., Lubitz, S. A., Passeri, J. J., et al. (2026) · Heart Rhythm O2 · doi:10.1016/j.hroo.2026.03.021 · Cited by 1
Therapeutisches Management des nichtvalvulären Vorhofflimmerns: Update 2013
Bode, K., Sommer, P., Bollmann, A., & Hindricks, G. (2013) · Herz · doi:10.1007/s00059-013-3940-x · Cited by 1
¿Cómo reducir los accidentes cerebrovasculares en Latinoamérica? Parte 1
Avezum, Á., Cantú, C., González‐Zuelgaray, J., Hills, M. T., Lobban, T., Massaro, A. R., Meschengieser, S. S., Norrving, B. G., & Reyes-Caorsi, W. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Atrial fibrillation: state of the art
Hasun, M., Gatterer, E., & Weidinger, F. F. (2014) · Wiener klinische Wochenschrift · doi:10.1007/s00508-014-0667-5 · Cited by 3
Complexity reduction in human atrial modeling using extended Kalman filter
Alagöz, C., Phatharodom, S., & Guez, A. (2018) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-018-1921-1 · Cited by 1
Zhao, K., Xiao, L., Zhao, M., & Ji, C. (2017) · PubMed · Cited by 1
Bittinger, L., & TANG, A. S. L. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.364 · Cited by 2
Hinga, A., Ibrahim, A., Vintimilla, D., Jones, M., Eckstein, L., Rid, A., Shah, S. K., & Kamuya, D. (2024) · BMJ Global Health · doi:10.1136/bmjgh-2024-015233 · Cited by 3
Dextrans as anticoagulants and antiplatelet agents: protocol for a scoping review
Flinkier, A., Dewapura, S., Tran, H., Yin, Z., Tran, N., Berman, J., Ratnasekara, V., Raykateeraroj, N., Fink, M. A., Lee, D. K., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-092284 · Cited by 1
THE INCIDENCE AND POSSIBLE CAUSES OF ATRIAL FIBRILLATION IN HOSPITALIZED PATIENTS DURING 1985–2010
Листопад, О. В., Jatsuk, D., & Баранова, Е. И. (2013) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2013-19-2-109-116 · Cited by 1
Costos asociados a la fibrilación auricular
Díaz-Martínez, J. C., Duque-Ramírez, M., Marín-Velásquez, J. E., Aristizábal, J. M., Velásquez-Vélez, J. E., & Uribe, W. (2016) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.10.029 · Cited by 1
Lang, A., Edwards, F. M., Norton, D., Semple, L., & Williams, H. (2020) · Future Healthcare Journal · doi:10.7861/fhj.2019-0033 · Cited by 1
A novel contact-free atrial fibrillation monitor: a pilot study
Sadeh, B., Merdler, I., Sadon, S., Lupu, L., Borohovitz, A., Ghantous, E., Taieb, P., Granot, Y. N., Goldstein, O., Soriano, J. C., et al. (2021) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztab108 · Cited by 1
Finding atrial fibrillation: just keep looking, just keep looking … (but remember stroke prevention)
Lip, G. Y. H. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12118 · Cited by 1
Self-citationHendrikx, T. (2015) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 1
Choosing antithrombotics for atrial fibrillation in primary care
Mustafa, M., & Sheppard, J. P. (2020) · British Journal of General Practice · doi:10.3399/bjgp20x708317 · Cited by 1
Evidence of the Impact of Programmes to Prevent and Manage Heart Disease and Stroke
Lee, V. W. Y., Wang, S. Y., Li, J. T. S., & Lam, A. S. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-50247-8_81-1 · Cited by 1
Aklilu, T., Kebede, M. A., Mekonnen, D., Asrat, Y., Petros, A., & Mekonnen, D. (2023) · medRxiv · doi:10.1101/2023.08.09.23293906 · Cited by 1
Wambiya, E. O. A., Gillespie, D., Akparibo, R., Oguta, J. O., Akoth, C., Otieno, P., & Dodd, P. J. (2024) · medRxiv · doi:10.1101/2024.10.19.24315798 · Cited by 1
Schlaganfallprävention versus Blutungsrisiko beim älteren Vorhofflimmernpatienten
Károlyi, L., & Spitzer, S. G. (2009) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-009-0065-0
Davis, R., Hobbs, R. F., Kenkre, J. E., Roalfe, A. K., Iles, R., Lip, G. Y. H., & Davies, M. K. (2013) · Redalyc (Universidad Autónoma del Estado de México)
Self-citationAtrial fibrillation: Reducing risks and enhancing lives
Nazarko, L. (2015) · British Journal of Healthcare Management · doi:10.12968/bjhc.2015.21.5.208
Potential use of amiodarone to treat new-onset AF in the pre-hospital setting
Brown, P. (2014) · Journal of Paramedic Practice · doi:10.12968/jpar.2014.6.8.408
Khoo, C. W., Lim, H. S., & Lip, G. Y. H. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.83
Self-citationThe Impact of Early Detection of Atrial Fibrillation on Stroke Outcomes
Tomson, T. T., Greenland, P., & PASSMAN, R. S. (2014) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2013.10.008 · Cited by 2
Prolonged Rhythm Monitoring in the Patient with Stroke and Transient Ischemic Attack
Seet, R. C. S., & Rabinstein, A. A. (2013) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2013.05.006
Lip, G. Y. H. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.10.015
Self-citationHow Can We Avoid a Stroke Crisis in Europe
Andreotti, F., Camm, A. J., & Lobban, T. (2012)
Meschia, J. F., Moore, W. S., Pearson, T. A., Hart, R. G., Hinchey, J. A., Howard, V. J., Jauch, E. C., Chaturvedi, S., Creager, M. A., Culebras, A., et al. (2010)
Stroke detection and prevention in atrial fibrillation
Hobbs, R. F. (2015) · British Journal of General Practice · doi:10.3399/bjgp15x685513
ANTI-ARRHYTHMIC TREATEMENT AND ELDERLY - WHERE ARE WE NOW?
Alexa, I. D., Rusu, R. I., Ungureanu, G., & MOŞ, L. M. (2009)
Листопад, О. В., Jatsuk, D., Баранова, Е. И., & Lang, G. F. (2013) · CyberLeninK (CyberLeninka)
Stepwise Approach for Ablation of Persistent Atrial Fibrillation
Wright, M. J., Miyazaki, S., & Haïssaguerre, M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-1368-8.00018-0
Stroke and mortality after atrial fibrillation—a global struggle
Larsen, T. B., & Nielsen, P. B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31274-0
Lahoz-Tornos, Á. (2015) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Murray, T. A., HOLDER, R. L., Davies, M., Mant, J., Fitzmaurice, D. A., Hobbs, R. F., & Jowett, S. M. (2007)
Self-citationScreening for atrial fibrillation in high-risk individuals : a stroke preventive effort
Svennberg, E. (2016) · Figshare
Sampson, M. G. (2017) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2017.12.6.265
Health Economic Evaluations of Screening Programs - Applications and Method Improvements
Aronsson, M. (2017) · doi:10.3384/diss.diva-141556
“[52, 54-56] Screening may help in decreasing the risk of stroke, providing positive effects such as reduced mortality and morbidity.”
BackgroundScreening, optimization, support: a call for stroke prevention in atrial fibrillation
Induruwa, I., Liu, W., & Khadjooi, K. (2018) · British Journal of Hospital Medicine · doi:10.12968/hmed.2018.79.8.424
Atrial Fibrillation Episodes of Illness in a Primary Care Setting
Tarasevich, A. (2019) · Scholarship@Western (Western University)
Diagnosis and prognostic value of asymptomatic atrial fibrillation
Pavlyk, N. S., Chernyaha-Royko, U., Sorokivskyy, M., Aker, A. V., & Zharinov, O. J. (2019) · Cardiac Surgery and Interventional Cardiology · doi:10.31928/2305-3127-2019.2.521
Screening for atrial fibrillation and treatment with anticoagulant to prevent stroke
Ghazal, F. (2020) · Figshare
Metadata
- Authors
- Hobbs, F., Fitzmaurice, D., Mant, J., Murray, E., Jowett, S., Bryan, S., Raftery, J., Davies, M., & Lip, G.
- Affiliations
- University of Birmingham (GB)
- Selly Oak Hospital (GB)
- Birmingham City Hospital (GB)
- Venue
- Health Technology Assessment
- Published
- 2005-10
- Volume
- 9
- Issue
- 40
- Pages
- iii-iv, ix
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2018796325
- Semantic Scholar
- 6a762d2e553123cd54cf721ab5362f51c0e3da53
- Cited by
- 437
- References
- 60
- Citations by year
- 2026: 13 · 2025: 25 · 2024: 24 · 2023: 17 · 2022: 32 · 2021: 27 · 2020: 35 · 2019: 27 · 2018: 34 · 2017: 25 · 2016: 31 · 2015: 23 · 2014: 27 · 2013: 26 · 2012: 18
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Health Technology Assessment (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- ePrints Soton (University of Southampton) (submittedVersion)
- Apollo
- Funders
- Health Technology Assessment programme (96/22/11)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- atrial fibrillation, systematic screening, opportunistic screening, targeted screening, cost-effectiveness, ECG interpretation, irregular pulse, atrial fibrillation prevalence, atrial fibrillation incidence, older adults, primary care, atrial fibrillation risk factors, practice nurses, general practitioners, atrial fibrillation mortality
- MeSH terms
- Aged, Atrial Fibrillation, Cost-Benefit Analysis, Electrocardiography, Female, United Kingdom, Humans, Male, Mass Screening, Primary Health Care, Risk Factors, Incidence, Prevalence, Outcome Assessment, Health Care, Sample Size
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.